SecSonar.com

Codexis, Inc. (CDXS)

Codexis, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Codexis, Inc. (CDXS) is a Biotechnology company based in US with a market capitalization of $258.1M. Revenue grew 18.6% year-over-year and free cash flow was negative at -$23.8M. This page tracks CDXS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 188 employees · IPO Apr 22, 2010

Valuation

Valuation & price

$2.46 · as of May 17, 2026 · -26.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

5.11

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.33$2.17$1.02Jul 25Dec 25Jun 26Jul 7, 25$2.58Jul 9, 25$2.91Jul 11, 25$2.99Jul 15, 25$2.81Jul 17, 25$2.88Jul 21, 25$2.84Jul 23, 25$3.33Jul 25, 25$3.11Jul 29, 25$2.82Jul 31, 25$2.68Aug 4, 25$2.84Aug 6, 25$2.86Aug 8, 25$2.77Aug 12, 25$2.86Aug 14, 25$3.10Aug 18, 25$3.00Aug 20, 25$2.82Aug 22, 25$2.89Aug 27, 25$2.67Aug 29, 25$2.73Sep 3, 25$2.41Sep 5, 25$2.42Sep 9, 25$2.45Sep 11, 25$2.44Sep 15, 25$2.44Sep 17, 25$2.35Sep 19, 25$2.45Sep 23, 25$2.46Sep 25, 25$2.40Sep 29, 25$2.47Oct 1, 25$2.50Oct 3, 25$2.54Oct 7, 25$2.56Oct 9, 25$2.68Oct 13, 25$2.50Oct 16, 25$2.64Oct 20, 25$2.74Oct 22, 25$2.56Oct 24, 25$2.70Oct 28, 25$2.59Oct 30, 25$2.36Nov 3, 25$2.26Nov 5, 25$2.15Nov 7, 25$1.69Nov 11, 25$1.80Nov 13, 25$1.63Nov 17, 25$1.57Nov 19, 25$1.62Nov 21, 25$1.54Nov 25, 25$1.68Nov 28, 25$1.73Dec 2, 25$1.65Dec 5, 25$1.83Dec 9, 25$1.87Dec 11, 25$1.71Dec 15, 25$1.63Dec 17, 25$1.61Dec 19, 25$1.66Dec 23, 25$1.65Dec 26, 25$1.63Dec 30, 25$1.60Jan 2, 26$1.61Jan 6, 26$1.72Jan 8, 26$1.68Jan 12, 26$1.68Jan 14, 26$1.78Jan 16, 26$1.67Jan 21, 26$1.71Jan 23, 26$1.68Jan 28, 26$1.29Jan 30, 26$1.24Feb 3, 26$1.36Feb 5, 26$1.27Feb 9, 26$1.29Feb 11, 26$1.19Feb 13, 26$1.20Feb 18, 26$1.17Feb 20, 26$1.17Feb 24, 26$1.11Feb 26, 26$1.07Mar 2, 26$1.02Mar 4, 26$1.08Mar 6, 26$1.23Mar 10, 26$1.24Mar 12, 26$1.71Mar 16, 26$1.50Mar 19, 26$1.67Mar 23, 26$1.61Mar 25, 26$1.75Mar 27, 26$1.58Mar 31, 26$1.63Apr 2, 26$1.82Apr 7, 26$1.98Apr 9, 26$2.40Apr 13, 26$2.30Apr 15, 26$2.46Apr 17, 26$2.59Apr 21, 26$2.41Apr 23, 26$2.52Apr 27, 26$2.65Apr 29, 26$2.81May 1, 26$2.67May 5, 26$2.75May 8, 26$2.85May 12, 26$2.54May 14, 26$2.57May 18, 26$2.55May 20, 26$2.58May 22, 26$2.49May 27, 26$2.64May 29, 26$2.77Jun 2, 26$2.69Jun 4, 26$2.80Jun 8, 26$2.61Jun 10, 26$2.35Jun 12, 26$2.40Jun 16, 26$2.48Jun 18, 26$2.57Jun 23, 26$2.39Jun 29, 26$2.33
$0.9852-week range$3.33
Loading valuation history…

Fundamentals

Key fundamentals

$258.1M

Market cap

18.6%

Revenue growth (YoY)

86.7%

Gross margin

-$23.8M

Free cash flow (USD)

-$5M

Net debt

Net cash position

18.7%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$48.8MFY 2017$50.0MFY 2018$60.6MFY 2019$68.5MFY 2020$69.1MFY 2021$104.8MFY 2022$138.6MFY 2023$70.1MFY 2024$59.3MFY 2025$70.4M
$48.8M$70.4M

Free cash flow by year

2016 → 2025

FY 2016$-3.6MFY 2017$-9.7MFY 2018$-16.9MFY 2019$-16.3MFY 2020$-20.2MFY 2021$-28.1MFY 2022$3.0MFY 2023$-57.1MFY 2024$-53.7MFY 2025$-23.8M
-$3.6M-$23.8M

Gross margin by year

2021 → 2025

FY 202178.8%FY 202272.6%FY 202381.7%FY 202472.5%FY 202586.7%
78.8%86.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 22, 2026Filing
  • Insider sellInsider Sell $6KDe Vre Raymond · Director · $6.2KJun 11, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventBoard Resignation and RebalanceApr 14, 2026Filing

Questions

Frequently asked questions

What is Codexis, Inc.'s market cap?

Codexis, Inc. (CDXS) has a market capitalization of $258.1M.

What is CDXS's P/E ratio?

A meaningful P/E ratio is not available for CDXS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CDXS's price-to-book (P/B) ratio?

CDXS trades at 5.11 times book value per share.

Are insiders buying CDXS stock?

SEC Form 4 filings show no open-market insider buys at Codexis, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Biotechnology

IVA

Inventiva S.A.

$259.9M

CGEN

Compugen Ltd.

$254.8M

FHTX

Foghorn Therapeutics Inc.

$253.6M

STRO

Sutro Biopharma, Inc.

$251.1M

LENZ

LENZ Therapeutics, Inc.

$249.3M

MGNX

MacroGenics, Inc.

$270.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.